By way of derogation from Article 4(2), Member States may approve, for a maximum period of 10 years, basic material intended for the production of FRM of the ‘tested’ category where the provisional results of the genetic evaluation or comparative tests referred to in Annex V support the assumption that, once the tests are completed, the basic material will satisfy the requirements for approval under this Regulation.
The Commission may adopt an implementing act specifying the maximum number of units of approval and the maximum area size that can be subject to such approval.
That implementing act shall be adopted in accordance with the examination procedure referred to in Article 32(2).